CHOLESTENIX LIMITED
Significant control: Oxandia Limited (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Cholestenix Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Cholestenix Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CHOLESTENIX LIMITED is an active private limited company (company number 08771706) incorporated on 12 November 2013, registered in Swansea. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 November 2024, showing net assets of −£93k, with 2 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 30% on the prior period (−£132k).
By net assets it sits in the bottom quarter of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Oxandia Limited
- owns 25–50% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Professor Ernest Arenas
- owns 25–50% of shares
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 12 November 201312 yrs ago
- Next accounts due
- 30 August 202656 days overdue
- Confirmation statement due
- 26 November 2026in 32 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2024 | −£93k | — | — | £101k | — | — | 2 |
| 30 November 2023 | −£132k | — | — | £133k | — | — | 2 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets below zeroNet assets £-92,988 at 30 November 2024
- Net assets up 10% or more on the prior period+29.7% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.08
- Incorporated five or more years agoIncorporated 12 November 2013
- Accounts past their due dateDue 30 August 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 32 days
- Next accounts due56 days overdue
- Accounts period endNet liabilities £93k · micro accounts
- Accounts period endNet liabilities £132k · micro accounts
- Incorporated
Similar companies in Swansea
- THE PROFESSIONALS NETWORK LTDMilford Haven · inc. Oct 2013
- BIONEMA GROUP LIMITEDSwansea · inc. Jun 2012
- PRUEX LTDLlanelli · inc. Sept 2016
- PINNADERM LTDBurry Port · inc. Jul 2010
- ALGAE SAVES THE WORLD, CONSULTING LTDCardigan · inc. Sept 2017
- GROVE NANOMATERIALS LIMITEDSwansea · inc. Mar 2018
All companies incorporated on 12 November 2013 · in Nov 2013.
Reminders for CHOLESTENIX LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.